- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Uganda Offering New Opportunities for Cannabis Cultivation
EXMceuticals (CSE:EXM) has announced the company has received its formal license for the cultivation, extraction, and exportation of cannabis and cannabis derivatives including extracts and oils.
EXMceuticals (CSE:EXM) has announced the company has received its formal license for the cultivation, extraction, and exportation of cannabis and cannabis derivatives including extracts and oils. The company intends to begin planting over 100 hectares immediately. EXMceuticals currently owns cultivation and production facilities that cover 2,000 hectares of agricultural land which is capable of housing 21,500 square feet of cannabis lab, extraction, and handling facilities. The company intends to use its Ugandan extraction facility to produce CBD oil in accordance with Ugandan regulatory authorities.
In addition to its facilities in the Republic of Malawi, EXMceuticals now owns over 84,000 hectares of land licensed for cannabis production across multiple jurisdictions. The company intends to create over 1,200 new jobs across Africa within the first two years of commercial production.
“This is a very major milestone for EXM as we continue to expand our operations in African countries which suit our strict operating criteria. Our aim is to be the largest volume, lowest cost producer and most secure supply-chain solution providers of cannabis extracted ingredients to the pharmaceutical, therapeutical, neutraceutical and cosmetic markets, all of which have received an explosion of demand in recent times.” said Michel Passebon, Chief Executive Officer of EXMceuticals.
To read the full release, click here.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.